Origin Materials (ORGN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
6 Jan, 2026Executive summary
Special meeting scheduled for February 17, 2026, to address key corporate actions.
Shareholders are invited to vote virtually or by proxy on significant proposals.
Voting matters and shareholder proposals
Proposal to amend the certificate of incorporation to effect a reverse stock split at a ratio between one-for-two and one-for-fifty, at the board's discretion.
Proposal to approve issuance of more than 20% of outstanding shares upon conversion of senior secured convertible notes issued under a securities purchase agreement dated November 13, 2025, as amended December 22, 2025.
Board recommends voting in favor of both proposals.
Additional business may be addressed if properly brought before the meeting.
Board of directors and corporate governance
Board of directors retains discretion to determine the exact ratio for the reverse stock split.
Latest events from Origin Materials
- Stockholders approved a reverse split and major share issuance, advancing strategic milestones.ORGN
EGM 202618 Feb 2026 - $100M+ PET cap deal signed; Q2 loss $19.5M; Q4 2024 production on track.ORGN
Q2 20241 Feb 2026 - Strong PET cap demand, $100M+ MOU, and EBITDA positivity targeted for 1H 2026.ORGN
Q3 202414 Jan 2026 - Rapid transformation to PET caps leverages technical strengths, innovation, and scalable growth.ORGN
Fireside Chat9 Jan 2026 - Approval sought for reverse split and convertible note share issuance to support listing and funding.ORGN
Proxy Filing6 Jan 2026 - Commercial PET cap production launched; 2026 revenue projected at $110M–$140M, EBITDA positive by year-end.ORGN
Q4 202426 Dec 2025 - Approval sought for reverse split and share issuance to support listing and financing.ORGN
Proxy Filing23 Dec 2025 - High demand and technical leadership drive confidence in growth and successful CapFormer deployment.ORGN
Investor Q&A19 Dec 2025 - Commercial PET cap production and revenue ramping up, with major growth expected by 2026.ORGN
Investor Q&A19 Dec 2025